Pulmonx Corporation Price to Book Ratio 2019-2024 | LUNG
Historical price to book ratio values for Pulmonx Corporation (LUNG) over the last 10 years. The current price to book ratio for Pulmonx Corporation as of February 21, 2025 is 3.77.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Pulmonx Corporation Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-02-21 | 8.96 | 3.77 | |
| 2024-09-30 | 8.29 | $2.38 | 3.49 |
| 2024-06-30 | 6.34 | $2.58 | 2.45 |
| 2024-03-31 | 9.27 | $2.85 | 3.26 |
| 2023-12-31 | 12.75 | $3.07 | 4.15 |
| 2023-09-30 | 10.33 | $3.28 | 3.15 |
| 2023-06-30 | 13.11 | $3.52 | 3.72 |
| 2023-03-31 | 11.18 | $3.81 | 2.93 |
| 2022-12-31 | 8.43 | $4.10 | 2.06 |
| 2022-09-30 | 16.66 | $4.37 | 3.81 |
| 2022-06-30 | 14.72 | $4.62 | 3.19 |
| 2022-03-31 | 24.81 | $4.91 | 5.05 |
| 2021-12-31 | 32.07 | $5.23 | 6.13 |
| 2021-09-30 | 35.98 | $5.51 | 6.53 |
| 2021-06-30 | 44.12 | $5.74 | 7.69 |
| 2021-03-31 | 45.74 | $6.05 | 7.56 |
| 2020-12-31 | 69.02 | $6.34 | 10.89 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.354B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||